It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
A new approach to killing cancer cells that uses a patient's own immune system has beaten back leukemia in 88 percent of adults, US researchers said today.
The report by scientists in New York offers more good news for the burgeoning field of cancer immunotherapy, which uses what some describe as a "living drug" that was hailed by Science magazine as the breakthrough of 2013.
The latest trial, published in the journal Science Translational Medicine, involved 16 people with a kind of blood cancer known as adult B cell acute lymphoblastic leukemia (ALL).
Some 1,400 people die of ALL in the United States each year, and while it is among the most treatable cancers, patients often become resistant to chemotherapy and eventually relapse.
The process involves removing some of the patient's T-cells and altering them with a gene to make them recognize a protein, known as CD19, on the cancer cells, so that they can attack them.
Left to their own devices, T cells can attack other harmful invaders in the body but will allow cancer to grow uninterrupted.
"Basically, what we do is re-educate the T cell in the laboratory with gene therapy to recognize and now kill tumor cells," Brentjens said.
UnBreakable
This procedure won't see the light of day in the general population. How else will big pharma make their billions of dollars if they cure 88% of leukemia sufferers? All thiose research grants and chemo treatments will be lost.
Lompyt
reply to post by SuperFrog
"Basically, what we do is re-educate the T cell in the laboratory with gene therapy to recognize and now kill tumor cells," Brentjens said.
Or you could just use high dose liposamal vitamin c to give the immune system a good helping hand. Theres plenty of people on here who know how to make there own. It works.
UnBreakable
This procedure won't see the light of day in the general population. How else will big pharma make their billions of dollars if they cure 88% of leukemia sufferers? All thiose research grants and chemo treatments will be lost.
UnBreakable
This procedure won't see the light of day in the general population. How else will big pharma make their billions of dollars if they cure 88% of leukemia sufferers? All thiose research grants and chemo treatments will be lost.
if they cure 88% of leukemia sufferers? All thiose research grants and chemo treatments will be lost.
BDBinc
reply to post by SuperFrog
Tell me in this phase 1 trial of 16 people, if now 3 are in" remission" (who also had bone marrow transplants) how is that it says 88%?
Already a patented and marketed $ therapy $ after a phase 1 trial of 16 people with 3 in remission post [multiple] other treatments.
How does he get to claim at this point in the small phase 1 study it is from his cell engineering and not from the chemo, the bone marrow transplants , placebo effect or other?
SuperFrog
BDBinc
reply to post by SuperFrog
Tell me in this phase 1 trial of 16 people, if now 3 are in" remission" (who also had bone marrow transplants) how is that it says 88%?
Already a patented and marketed $ therapy $ after a phase 1 trial of 16 people with 3 in remission post [multiple] other treatments.
How does he get to claim at this point in the small phase 1 study it is from his cell engineering and not from the chemo, the bone marrow transplants , placebo effect or other?
If you read first post and article, you would notice that those are patients that chemo or other treatment did not work. When they started with this therapy, they were very close to death and out of options. This drug saved their lives.
I guess that those who study this therapy took daily samples to verify progress and to see if therapy is helping or not.